PDUFA Dates: January 2027
1 FDA target action date in January 2027. Each PDUFA date is the FDA's deadline to complete review of a drug application.
A single FDA target action date this month — Foundayo (orforglipron) from Eli Lilly and Company for Chronic weight management in adults with obesity or overweight.
Eli Lilly and Company LLY APPROVED
Foundayo (orforglipron) Chronic weight management in adults with obesity or overweight Metabolic
NDA
Jan 20, 2027
186 days